Close

Karen's Story

I live with emphysema (a long-term lung condition) caused by a rare condition called Alpha-1 Antitrypsin Deficiency (AATD). This means my body does not produce enough of a protein that protects my lungs, and over time this has caused significant damage. Living with this condition affects almost every part of my daily life.

I live on my own and, while I don’t have a carer, I do rely on some support. I have a cleaner because I struggle with everyday household tasks. I am on oxygen for around 15 hours a day, and even simple activities leave me breathless. I can only walk short distances and getting out and about can be difficult, although I still enjoy going shopping and rely heavily on my car to keep some independence.

My involvement with research began through the Alpha-1 clinics I attend at my local hospital. I was contacted by Dr Lara at UHCW, who explained a research study to me and asked whether I would be interested in taking part. The study was designed to test a new treatment on a group of people (up to 100) with my specific condition, with a focus on safety and dosage.

At the time, my only other treatment option was a lung transplant, which was not something I wanted to pursue. I had heard about similar trials taking place in the United States, so when I found out there was an opportunity to take part in one here in the UK, and not too far from where I live, I felt genuinely excited. It felt like a chance to do something proactive rather than just waiting for my condition to worsen.

I went into the research study with realistic expectations. I understood that it might not help me personally, but I hoped it could lead to better treatments for others in the future. Everything was explained clearly, and I was given plenty of time to ask questions. I also knew that I could withdraw from the study at any point if I changed my mind, which helped me feel in control of my decision.

Being part of the study has been a very positive experience for me. The trial involved coming into hospital every three weeks over three years, which would have been a total of 156 visits.

During this time, I underwent regular physical examinations, blood tests, ECGs, lung function tests, CT scans, and discussions about my health and medications. Although it sounds like a lot, I never felt overwhelmed, I also did not experience any side effects from the treatment.

What made the biggest difference was the research team. They were incredibly supportive, helpful, and approachable. I always felt listened to and cared for, and I actually enjoyed coming in for my visits. Having that regular contact and feeling part of something important gave me a real sense of purpose.

Since taking part in the study, I have not had any further exacerbations of my condition. However, in September 2025, I made the decision to withdraw from the trial because I was offered the opportunity to undergo endobronchial surgery, something I had been waiting for, for a long time. This was not an easy decision, but it was the right one for me at that stage.

If I could give advice to anyone thinking about taking part in research, it would be to carefully consider whether you can commit to it. Talk things through with family and friends, as their support is important. It isn’t always easy, and there may be challenges along the way where you need to ask for help. However, even if the study does not benefit you directly, you are leaving a legacy and helping to improve care for others in the future.

I would absolutely take part in a research study again if I were able to. Being involved reminded me that patients are not just recipients of treatment—we are partners in shaping the future of healthcare.